tiprankstipranks
Trending News
More News >
Intensity Therapeutics, Inc. (INTS)
NASDAQ:INTS
US Market
Advertisement

Intensity Therapeutics, Inc. (INTS) Similar Stocks

Compare
192 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Intensity Therapeutics, Inc.
$1.32
$11.67M
-0.29
-59.38%
2 Buy
0 Hold
0 Sell
Moderate Buy
Biodexa Pharmaceuticals
$6.11
$3.79M
-0.09
-89.79%
0 Buy
0 Hold
0 Sell
Moderate Buy
Q/C Technologies
$3.38
$10.06M
-0.01
-97.46%
Salarius Pharmaceuticals
$3.84
$4.04M
-0.08
-84.10%
Scinai Immunotherapeutics
$1.46
$1.25M
0.30
-58.99%
Oragenics
$1.23
$5.08M
-0.05
-86.66%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
INTS
Intensity Therapeutics, Inc.
1.32
-2.00
-60.24%
BDRX
Biodexa Pharmaceuticals
6.33
-52.77
-89.29%
QCLS
Q/C Technologies
3.38
-129.62
-97.46%
SLRX
Salarius Pharmaceuticals
3.84
-18.36
-82.70%
SCNI
Scinai Immunotherapeutics
1.46
-2.10
-58.99%
OGEN
Oragenics
1.23
-7.68
-86.20%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis